The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tucatinib, palbociclib, and letrozole in HR+/HER2+ metastatic breast cancer: Report of phase IB safety cohort.
 
Elena Shagisultanova
Research Funding - Pfizer
 
Pavani Chalasani
Consulting or Advisory Role - AstraZeneca; Bayer; HERON; NanoString Technologies
Research Funding - Pfizer
 
Ursa Abigail Brown-Glaberman
Consulting or Advisory Role - Novartis; Syndax
Research Funding - Seagen (Inst)
 
William John Gradishar
Consulting or Advisory Role - Genentech/Roche
 
Andrew Jacob Brenner
Honoraria - Vascular Biogenics
Consulting or Advisory Role - NanoTX; Vascular Biogenics
Research Funding - miRNA Therapeutics (Inst); Threshold Pharmaceuticals; Vascular Biogenics
Patents, Royalties, Other Intellectual Property - I have intellectual property interest in NanoTx Therapeutics
Travel, Accommodations, Expenses - Vascular Biogenics
 
Alison Stopeck
Honoraria - Amgen; Genomic Health
Consulting or Advisory Role - Amgen; AstraZeneca; Biothera; Celgene; Immunomedics; Sandoz-Novartis
Speakers' Bureau - Genomic Health
Research Funding - Amgen (Inst); AstraZeneca (Inst); Genomic Health (Inst)
 
Dexiang Gao
No Relationships to Disclose
 
Tessa McSpadden
No Relationships to Disclose
 
Peter Kabos
Consulting or Advisory Role - Lilly
Research Funding - Radius Health (Inst)
 
Virginia F. Borges
Research Funding - Abbott/AbbVie (Inst); Advaxis (Inst); Galena Biopharma (Inst); Incyte (Inst); Merrimack (Inst); Oncothyreon (Inst)